With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. For more information, please visit http://aeglea.com.
View Top Employees from Aeglea BioTherapeutics| Website | http://www.aeglea.com |
| Ticker | AGLE |
| Employees | 84 (84 on RocketReach) |
| Founded | 2013 |
| Address | 805 Las Cimas Pkwy Suite 100, Austin, Texas 78746, US |
| Phone | (512) 942-2935 |
| Fax | (512) 872-5121 |
| Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Therapeutics |
| Web Rank | 5 Million |
| Keywords | Aegela Austin, Aeglea Bio Therapeutics, Aeglea Biotherapeutics, Chief Medical Officer Pharmaceutical Industry, Aeglea |
| Competitors | AGY Therapeutics, Inc., Calithera Biosciences, Embera NeuroTherapeutics, Evelo Biosciences, Halozyme, Inc. |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325414 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Aeglea BioTherapeutics employee's phone or email?
Aeglea BioTherapeutics Questions
Jonathan Alspaugh is the CFO of Aeglea BioTherapeutics.
84 people are employed at Aeglea BioTherapeutics.
Aeglea BioTherapeutics is based in Austin, Texas.
The NAICS codes for Aeglea BioTherapeutics are [325414, 3254, 325, 32541, 32].
The SIC codes for Aeglea BioTherapeutics are [283, 28].
Top Aeglea BioTherapeutics Employees
-
5+5+
-
31
-
3
-
45
-
55+
-
ViewMichael Schopp
VP, Commercial Operations and Alliance Management at Aeglea BioTherapeutics
Chicago, Illinois, United States44
Related Companies
